Literature DB >> 17017435

Role of fine needle aspiration cytology in nodular sclerosis variant of Hodgkin's lymphoma.

Sanjay Jogai1, Pranab Dey, Aisha Al Jassar, H G Amanguno, Aaron O Adesina.   

Abstract

OBJECTIVE: To assess the efficacy of fine needle aspiration cytology (FNAC) in the diagnosis of nodular sclerosis variant of Hodgkin's lymphoma (NSHL) and to analyze cytologic features that could help in subtyping a case of Hodgkin's lymphoma into this variant. STUDY
DESIGN: FNAC smears of 18 histopathologically proven cases of NSHL were analyzed for a variety of features.
RESULTS: On initial cytologic assessment, 14 of 18 cases were diagnosed as Hodgkin's lymphoma. No further subtyping was performed. In this retrospective analysis it was possible to revise the diagnosis in the remaining 4 cases. Of the various cytologic features analyzed, presence of numerous lacunar-type cells along with fibroblasts and collagenous material were useful pointers toward a diagnosis of nodular sclerosis variant. Fibroblasts were seen in 83.33%, collagenous material in 27.77% and numerous lacunar cells in 77.77%.
CONCLUSION: Subtyping of NSHL based on cytologic features alone has been a matter of debate for a long time. Of the various subtypes, nodular sclerosis poses the greatest diagnostic difficulty. Though certain cytologic features may help in suggesting a diagnosis of nodular sclerosis variant, the primary role of fine needle aspiration is to diagnose a case of Hodgkin's lymphoma as such and advise histopathologic examination for further categorization.

Entities:  

Mesh:

Year:  2006        PMID: 17017435     DOI: 10.1159/000326004

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  1 in total

1.  Fine-Needle Aspiration Diagnosis of Lymphoma Based on Cytomorphology Alone: How Accurate is it? - A Cyto-Histopathology Correlative Study.

Authors:  Sumit Garg; Manish Rohilla; Radhika Srinivasan; Amanjit Bal; Ashim Das; Pranab Dey; Nalini Gupta; Parikshaa Gupta; Arvind Rajwanshi
Journal:  J Cytol       Date:  2021-08-27       Impact factor: 1.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.